{"id":380182,"date":"2020-11-12T16:04:11","date_gmt":"2020-11-12T21:04:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380182"},"modified":"2020-11-12T16:04:11","modified_gmt":"2020-11-12T21:04:11","slug":"paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/","title":{"rendered":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that the Company will present at the 2020 Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 11:25 a.m. ET or 4:25 p.m. GMT.<\/p>\n<p>To access the live webcast of Paratek&#8217;s presentation, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7-C06OHFyWy0W3rE9-Gj_SvyVqhU99X_pN5_G7xMEj8rKEp47HqncAf6h1YWDZ-tEDWh86VKaSoIXMzEeOVyFNQ9YZLOa3R6fm2baey3bR-kmt_Vo5oiBWjM_FfxihApjCIiO9ckOkbtiTWRPbOBXY5vq1Tks112SM2f-sxkCix1_mTe0QyILVkCQsyhPTME93gPsS4Psh_Dz2N97kLN6CrxnN__16j1fZdSmRYwlzdi1QlMM4CLgSV2BGkBZKntaU00u0KgZYUe8OLVakUJzVnSfLlFh9Pxbq400J2h1ZH-rvRHNCQWOLCOc--NLKJ0Ee41WKzQhSHMFwqPSpijhnvxHzuoDc5aQx0Bc3KLBHJvlVDMH0drb-mP8difCG62B0LWjlbcq_qvIpQ7pJ-NHZbzel2hfDyh2AnXQByCvxPyghIVyD5TmIP-F4wOEqHDFjGOEguzHQ2WaMpmCB_MBloxXD6oWpVp8gC-kCPwAPMkyZ9XAHUyd1aoiAfXxIgWq3W6cJE4kCH16gUYLfSl4g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/wsw.com\/webcast\/jeff141\/paratek\/2291400<\/u><\/a>.<\/p>\n<p>Please connect to the web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up to 90 days following the live presentation.<\/p>\n<p>\n        <strong>About Paratek Pharmaceuticals, Inc.<\/strong><br \/>\n        <br \/>Paratek Pharmaceuticals, Inc.\u00a0is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use. <\/p>\n<p> The Company\u2019s lead commercial product, NUZYRA<sup>\u00ae<\/sup>\u00a0(omadacycline), is\u00a0a once-daily oral and intravenous antibiotic available in the U.S. for the treatment of adults with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Paratek has a collaboration agreement with\u00a0Zai\u00a0Lab for the development and commercialization of omadacycline in the greater\u00a0China\u00a0region and retains all remaining global rights.<\/p>\n<p> Paratek exclusively licensed U.S. rights and rights to the greater China territory for SEYSARA<sup>\u00ae<\/sup> (sarecycline), a once-daily oral therapy for the treatment of moderate to severe acne vulgaris, to\u00a0Almirall, LLC\u00a0(Almirall). Paratek retains the development and commercialization rights for sarecycline in the rest of the world.<\/p>\n<p> In 2019, Paratek was awarded a five-year contract from the Biomedical Advanced Research and Development Authority\u00a0(BARDA)\u00a0valued at up to $285 million, with an option to extend to ten years, to support the development of NUZYRA for the treatment of pulmonary anthrax,\u00a0FDA\u00a0post-marketing requirements (PMR) associated with the initial NUZYRA approval, and the option to procure up to 10,000 treatment courses of NUZYRA for the Strategic National Stockpile (SNS) for use against potential biothreats. <\/p>\n<p> For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8_Jn1F-9uZR0n-MpQeBcwQ7R2FjzF5wuYUbOQfUTCWj5UOzYnFOOadLDRoN2kP_995uMGrTgz0I_4G8sBjtzTgjZX_BvDVsmKdCeSmCgZ3s=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ParatekPharma.com<\/a>\u00a0or follow @ParatekPharma\u00a0on Twitter.<\/p>\n<p><strong>Forward Looking Statements\u00a0<\/strong><br \/>This press release contains forward-looking statements including statements related to our overall strategy, products, prospects and potential.\u00a0\u00a0All statements, other than statements of historical facts, included in this press release are forward-looking statements, and are identified by words such as &#8220;advancing,&#8221; &#8220;expect,&#8221; &#8220;look forward,&#8221; &#8220;anticipate,&#8221; &#8220;continue,&#8221; and other words and terms of similar meaning. These forward-looking statements are based upon our current expectations and involve substantial risks and uncertainties.\u00a0 We may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in our forward-looking statements and you should not place undue reliance on these forward-looking statements.\u00a0 Our actual results and the timing of events could differ materially from those included in such forward-looking statements as a result of these risks and uncertainties.\u00a0 These and other risk factors are discussed under &#8220;Risk Factors&#8221; and elsewhere in our Annual Report on Form 10-K for\u00a0the year ended December 31, 2019 and our other filings with the Securities and Exchange Commission.\u00a0 We expressly disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong>Investor and Media Relations:<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">Ben Strain<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">617-807-6688<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top\">\n            <a href=\"mailto:ir@ParatekPharma.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n              <u>ir@ParatekPharma.com<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that the Company will present at the 2020 Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 11:25 a.m. ET or 4:25 p.m. GMT. To access the live webcast of Paratek&#8217;s presentation, please visit https:\/\/wsw.com\/webcast\/jeff141\/paratek\/2291400. Please connect to the web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380182","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that the Company will present at the 2020 Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 11:25 a.m. ET or 4:25 p.m. GMT. To access the live webcast of Paratek&#8217;s presentation, please visit https:\/\/wsw.com\/webcast\/jeff141\/paratek\/2291400. Please connect to the web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up &hellip; Continue reading &quot;Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T21:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference\",\"datePublished\":\"2020-11-12T21:04:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/\"},\"wordCount\":562,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/\",\"name\":\"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\",\"datePublished\":\"2020-11-12T21:04:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk","og_description":"BOSTON, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and\u00a0military use, today announced that the Company will present at the 2020 Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 11:25 a.m. ET or 4:25 p.m. GMT. To access the live webcast of Paratek&#8217;s presentation, please visit https:\/\/wsw.com\/webcast\/jeff141\/paratek\/2291400. Please connect to the web site at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast can be accessed for up &hellip; Continue reading \"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T21:04:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference","datePublished":"2020-11-12T21:04:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/"},"wordCount":562,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/","name":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=","datePublished":"2020-11-12T21:04:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTEwOSMzODI0NTY5IzIwMjg2ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/paratek-pharmaceuticals-to-present-at-the-2020-jefferies-virtual-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Paratek Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380182"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380182\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}